Log in

Relevant bibliographies by topics / Personalized medicin / Journal articles

To see the other types of publications on this topic, follow the link: Personalized medicin.

Journal articles on the topic 'Personalized medicin'

Author: Grafiati

Published: 9 March 2023

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Personalized medicin.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Teixeira, Túlio Weslley Dantas, Maria Carolina Wanderley, and Roberta Luciana do Nascimento Godone. "Medicina personalizada no tratamento do câncer/Personalized medicine in cancer treatment." Brazilian Journal of Health Review 3, no. 6 (2020): 18789–93. http://dx.doi.org/10.34119/bjhrv3n6-266.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Teixeira, Túlio Weslley Dantas, Maria Carolina Wanderley, and Roberta Luciana do Nascimento Godone. "Medicina personalizada no tratamento do câncer/Personalized medicine in cancer treatment." Brazilian Journal of Health Review 3, no. 6 (2020): 18789–93. http://dx.doi.org/10.34119/bjhrv3n6-266.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pereginya, O. V. ,. "TRANSLATION MEDICINE, BIOMEDICINE AND MEDICAL BIOTECHNOLOGY: THE TRANSITION TO PERSONALIZED MEDICINE." Biotechnologia Acta 13, no. 2 (2020): 5–11. http://dx.doi.org/10.15407/biotech13.02.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kutty, Dr AVM. "Personalized Medicine : An Overview." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 08, no. 2 (2018): 36–38. http://dx.doi.org/10.58739/jcbs/v08i2.7.

Full text

Abstract:

The advancements in Science and Technology are paving way to reconsider the manner in which we define disease, drug development, diagnosis and treatment. The analytical capabilities of biological specimens have seen an explosion and have contributed tremendously to the diagnosis of diseases in general and genetic diseases in particular. There is a transformation of description of diseases from simple anatomical location and clinical symptoms which failed to take into consideration the unique biological profile of the patient, which could determine the therapeutic efficacy of the drugs being ad

APA, Harvard, Vancouver, ISO, and other styles

5

Awwalu, Jamilu, Ali Garba Garba, Anahita Ghazvini, and Rose Atuah. "Artificial Intelligence in Personalized Medicine Application of AI Algorithms in Solving Personalized Medicine Problems." International Journal of Computer Theory and Engineering 7, no. 6 (2015): 439–43. http://dx.doi.org/10.7763/ijcte.2015.v7.999.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

P, Ajmal Rasi K., and Puneeth Vishnukeerthy K. "Personalized Medicine Revolution Medicine based on Genomics Makeup." International Journal of Trend in Scientific Research and Development Volume-2, Issue-4 (2018): 433–39. http://dx.doi.org/10.31142/ijtsrd12982.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Singhal, Dr Udita. "Personalized Medicine: Evolving paradigm in Pathology." Recent Advances in Pathology & Laboratory Medicine 3, no. 2 (2017): 17–22. http://dx.doi.org/10.24321/2454.8642.201703.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Movafagh, Abolfazl. "Personalised Medicine in Modern Era." Asian Pacific Journal of Cancer Biology 1, no. 2 (2016): 31–32. http://dx.doi.org/10.31557/apjcb.2016.1.2.31-32.

Full text

Abstract:

Personalised Medicine is a medical procedure that separates patients into different groups-with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease. The terms personalized medicine, precision medicine, stratified medicine are used interchangeably to describe this concept.

APA, Harvard, Vancouver, ISO, and other styles

9

Suhonen, Riitta, Minna Stolt, and David Edvardsson. "Personalized Nursing and Health Care: Advancing Positive Patient Outcomes in Complex and Multilevel Care Environments." Journal of Personalized Medicine 12, no. 11 (2022): 1801. http://dx.doi.org/10.3390/jpm12111801.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tsvetanova, Kameliya. "The Patient as Target of Personalized Medicine." International Journal of Science and Research (IJSR) 10, no. 1 (2021): 1551–53. https://doi.org/10.21275/sr21128023659.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Gupta, OP. "Personalized Medicine." Journal of Mahatma Gandhi Institute of Medical Sciences 24, no. 1 (2019): 1. http://dx.doi.org/10.4103/jmgims.jmgims_10_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Dedov, Ivan I. "Personalized Medicine." Annals of the Russian academy of medical sciences 74, no. 1 (2019): 61–70. http://dx.doi.org/10.15690/vramn1108.

Full text

Abstract:

Evidence-based medicine at the end of the 20th century saved many lives, allowing us to reliably screen out pseudoscientific and dangerous methods. The medical community has gained access to weighted “standards” for treating common diseases. Unfortunately, this algorithmic approach pays for the breadth of coverage with low specificity of recommendations. In this article, the necessity and timeliness of the next step - the transition from broad clinical generalizations to working with the individual characteristics of the patient - are substantiated. The discussion opens with a forced criticism

APA, Harvard, Vancouver, ISO, and other styles

13

Eastman, Peggy. "‘Personalized Medicine’." Oncology Times 27, no. 20 (2005): 18–19. http://dx.doi.org/10.1097/01.cot.0000290951.75653.ad.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Sznajder, Jacob I., and Aaron Ciechanover. "Personalized Medicine." American Journal of Respiratory and Critical Care Medicine 186, no. 10 (2012): 945–47. http://dx.doi.org/10.1164/rccm.201210-1772oe.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Thrall, James H. "Personalized Medicine." Radiology 231, no. 3 (2004): 613–16. http://dx.doi.org/10.1148/radiol.2313040323.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Simone, Joseph V. "Personalized Medicine." Oncology Times 30, no. 9 (2008): 4. http://dx.doi.org/10.1097/01.cot.0000319869.33262.f0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Kornman, K. S., and G. W. Duff. "Personalized Medicine." Journal of Dental Research 91, no. 7_suppl (2012): S8—S11. http://dx.doi.org/10.1177/0022034512449171.

Full text

Abstract:

Human differences in disease phenotype and treatment responses are well documented. Technological advances now allow healthcare providers to improve the prevention and treatment of chronic diseases by stratifying patient populations. Although personalized medicine has great promise, it has, so far, been primarily applied in oncology. Wider adoption requires changes in the healthcare system and in clinical decision-making, and early applications of personalized medicine appear to require strong clinical utility and sufficient value to drive adoption. Personalized medicine is likely to enter den

APA, Harvard, Vancouver, ISO, and other styles

18

Rowell, Laurie. "Personalized medicine." netWorker 13, no. 4 (2009): 26–30. http://dx.doi.org/10.1145/1655737.1655744.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Norris, Patrick R., Jeffrey A. Canter, Judith M. Jenkins, Jason H. Moore, Anna E. Williams, and John A. Morris. "Personalized Medicine." Transactions of the ... Meeting of the American Surgical Association 127 (2009): 155–61. http://dx.doi.org/10.1097/sla.0b013e3181b8fb1f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

MULLIN, RICK. "PERSONALIZED MEDICINE." Chemical & Engineering News 86, no. 6 (2008): 17–27. http://dx.doi.org/10.1021/cen-v086n006.p017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Raparelli, Valeria, Muhammad Ahmer Wali, and Louise Pilote. "Personalized Medicine." JACC: Heart Failure 7, no. 8 (2019): 732–33. http://dx.doi.org/10.1016/j.jchf.2019.03.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Zarbin, Marco A. "Personalized Medicine." JAMA Ophthalmology 131, no. 7 (2013): 837. http://dx.doi.org/10.1001/jamaophthalmol.2013.5145.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Nardini, Christine, Venet Osmani, Paola G. Cormio, et al. "The evolution of personalized healthcare and the pivotal role of European regions in its implementation." Personalized Medicine 18, no. 3 (2021): 283–94. http://dx.doi.org/10.2217/pme-2020-0115.

Full text

Abstract:

Personalized medicine (PM) moves at the same pace of data and technology and calls for important changes in healthcare. New players are participating, providing impulse to PM. We review the conceptual foundations for PM and personalized healthcare and their evolution through scientific publications where a clear definition and the features of the different formulations are identifiable. We then examined PM policy documents of the International Consortium for Personalised Medicine and related initiatives to understand how PM stakeholders have been changing. Regional authorities and stakeholders

APA, Harvard, Vancouver, ISO, and other styles

24

Martaadisoebrata, Djamhoer. "Personalized Medicine dalam Pelayanan Kesehatan Reproduksi." Indonesian Journal of Obstetrics & Gynecology Science 2, no. 1 (2019): 1. http://dx.doi.org/10.24198/obgynia.v2i1.108.

Full text

Abstract:

AbstrakTujuan: Untuk mencoba mencari kejelasan kelemahan dan keunggulan berbagai paradigma dan mencoba membuktikan bahwa Personalized Medicine itu adalah paradigma yang terbaik, sampai saat ini.Metode: Studi PustakaHasil: Dengan seiring waktu Clinical Medicine juga mendapatkan tambahan pengembangan dari Evidence Based Medicine dan Genome Medicine. Personalized Medicine lebih mengembangkan ilmu kedokteran sesuai dengan individu masing-masing sehingga menjadi lebih baik.Kesimpulan: Walaupun terbukti bahwa Clinical Medicine, Evidence Based Medicine dan Genome Medicine mempunyai kelemahan di sampi

APA, Harvard, Vancouver, ISO, and other styles

25

Sharma, Himanshu, Urmi Bhadouria, Teenu Sharma, Arindam Chatterjee, and Parveen Kumar. "An Updated Overview on Personalized Medicine: The Next-Gen Paradigm." INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE 14, no. 02 (2023): 457–63. http://dx.doi.org/10.25258/ijpqa.14.2.34.

Full text

Abstract:

Personalized medicine is a translational approach that utilizes an individual’s genetic profile to guide illness prevention, diagnosis, and treatment choices. The human genome project data is being used to enhance personalized treatment. “Personalised” medicine is beneficial over “individualized” medicine as it suggests that future hazards may be predicted based on the individual’s genes. The advancement of technology for personalized medicine depends heavily on standardization, integration, and harmonization. The scientific practices at various research sites, the connection between science a

APA, Harvard, Vancouver, ISO, and other styles

26

Blum, H. E. "Molecular medicine - Personalized medicine." DMW - Deutsche Medizinische Wochenschrift 130, no. 25/26 (2005): 1568–72. http://dx.doi.org/10.1055/s-2005-870867.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Popović, Mitar, and Marina Jakšić. "Personalized medicine and pharmacogenomics." PONS - medicinski casopis 21, no. 2 (2024): 60–68. https://doi.org/10.5937/pomc21-51232.

Full text

Abstract:

Personalized medicine refers to any clinical approach that emphasizes the systematic use of preventive, diagnostic, and therapeutic interventions based on genomic and family history data to enhance health outcomes. In this sense, personalized treatment is frequently referred to as genomic medicine. Personalized medicine has several health strategies that rely on the identification of molecular-genetic markers, including molecular diagnosis, prognosis, and disease monitoring; predictive genetics and preventive medicine; pharmacogenomics; targeted molecular therapy, and gene-based therapy. This

APA, Harvard, Vancouver, ISO, and other styles

28

James Tabat Bature, Michael Alurame Eruaga, and Esther Oleiye Itua. "Integrating pharmacogenomic testing into personalized medicine practices in the USA: Implications for medication quality control and therapeutic efficacy." GSC Biological and Pharmaceutical Sciences 26, no. 3 (2024): 019–26. http://dx.doi.org/10.30574/gscbps.2024.26.3.0081.

Full text

Abstract:

This concept paper explores the integration of pharmacogenomic testing into personalized medicine practices in the USA and its implications for medication quality control and therapeutic efficacy. By leveraging genetic information to optimize medication selection and dosing, this paper aims to improve patient outcomes and minimize adverse drug reactions, thereby enhancing medication safety and efficacy in clinical practice. Integrating pharmacogenomic testing into personalized medicine practices has the potential to revolutionize healthcare by improving medication quality control and therapeut

APA, Harvard, Vancouver, ISO, and other styles

29

James, Tabat Bature, Alurame Eruaga Michael, and Oleiye Itua Esther. "Integrating pharmacogenomic testing into personalized medicine practices in the USA: Implications for medication quality control and therapeutic efficacy." GSC Biological and Pharmaceutical Sciences 26, no. 3 (2024): 019–26. https://doi.org/10.5281/zenodo.11044371.

Full text

Abstract:

This concept paper explores the integration of pharmacogenomic testing into personalized medicine practices in the USA and its implications for medication quality control and therapeutic efficacy. By leveraging genetic information to optimize medication selection and dosing, this paper aims to improve patient outcomes and minimize adverse drug reactions, thereby enhancing medication safety and efficacy in clinical practice. Integrating pharmacogenomic testing into personalized medicine practices has the potential to revolutionize healthcare by improving medication quality control and therapeut

APA, Harvard, Vancouver, ISO, and other styles

30

Romero-Garmendia, Irati, and Koldo Garcia-Etxebarria. "From Omic Layers to Personalized Medicine in Colorectal Cancer: The Road Ahead." Genes 14, no. 7 (2023): 1430. http://dx.doi.org/10.3390/genes14071430.

Full text

Abstract:

Colorectal cancer is a major health concern since it is a highly diagnosed cancer and the second cause of death among cancers. Thus, the most suitable biomarkers for its diagnosis, prognosis, and treatment have been studied to improve and personalize the prevention and clinical management of colorectal cancer. The emergence of omic techniques has provided a great opportunity to better study CRC and make personalized medicine feasible. In this review, we will try to summarize how the analysis of the omic layers can be useful for personalized medicine and the existing difficulties. We will discu

APA, Harvard, Vancouver, ISO, and other styles

31

Alahmari, Abdulwahab. "Numbers in radiology and personalized medicine: A commentary." International Journal of Clinical Case Reports and Reviews 8, no. 3 (2021): 01. http://dx.doi.org/10.31579/2690-4861/167.

Full text

Abstract:

Some of the numbers in radiology used as a criteria to make or role out a diagnosis for some conditions. These numbers should not be taken for granted since personalized medicine state that every patient is different and should be treated based on his/her condition. Those numbers can’t be used as a golden slandered in all case. This commentary will focus on some examples where numbers as a criteria failed or made the diagnosis impossible.

APA, Harvard, Vancouver, ISO, and other styles

32

Pradhan, Dr Dibyabhaba. "Biomedical Informatics: From Clinical Data to Personalized Medicine." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 04, no. 3 (2014): 301–2. http://dx.doi.org/10.58739/jcbs/v04i3.11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Borges, Anita M., and Murali Varma. "Personalized histopathology reporting for personalized medicine." Diagnostic Histopathology 27, no. 7 (2021): 275–78. http://dx.doi.org/10.1016/j.mpdhp.2021.04.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Cornetta, Kenneth, and Candy Gunther Brown. "Balancing Personalized Medicine and Personalized Care." Academic Medicine 88, no. 3 (2013): 309–13. http://dx.doi.org/10.1097/acm.0b013e3182806345.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Nassimbwa, Kabanda D. "The Role of Biomarkers in Personalized Cancer Treatment." RESEARCH INVENTION JOURNAL OF PUBLIC HEALTH AND PHARMACY 3, no. 2 (2024): 3–33. http://dx.doi.org/10.59298/rijpp/2024/323033.

Full text

Abstract:

Biomarkers are vital instruments in modern medicine, providing information about biological processes and disease progression. Biomarkers in oncology have had a substantial impact on the development of personalised cancer treatments by predicting therapy responses and outcomes. The study investigates the different types of biomarkers, such as diagnostic, prognostic, and predictive biomarkers, and their function in precision medicine. Personalised cancer treatment, which is guided by biomarker testing, improves patient outcomes by adapting medicines to individual genetic profiles. However, obst

APA, Harvard, Vancouver, ISO, and other styles

36

Volchek, Igor Vladimirovich, Andrey Stanislavovich Petrov, and Ekaterina Alexandrovna Osmalovskaya. "Personalized therapy with use of screening drugs in pediatrics." Pediatrician (St. Petersburg) 4, no. 2 (2013): 75–80. http://dx.doi.org/10.17816/ped4275-80.

Full text

Abstract:

Currently, personalized medicine is one of the most promising areas of medicine XXI century. We review the data on the use of screening drugs in vitro by its effect on the thiol-disulfide ratio (TDR) of blood for the personalized treatment of chronic hepatitis C, herpes and human papillomavirus infection, chronic bronchitis, repeated giardiasis in children and adults, as well as personalized immunotherapy of frequently ill children. It is concluded that this method can be used to personalize the antibacterial, antiviral, antiprotozoal and immunotherapy in children in order to increase its effi

APA, Harvard, Vancouver, ISO, and other styles

37

Mangampadath, Abhilash. "Integrating the concepts of Prakriti and Personalised Medicine in the practice of Ayurvedic immunology." Journal of Ayurveda and Holistic Medicine (JAHM) 13, no. 6 (2025): 130–37. https://doi.org/10.70066/jahm.v13i6.1822.

Full text

Abstract:

Introduction: Prakriti is the cornerstone of Ayurveda, on which the entire principles and practices are built upon. The concept of Prakriti is comparable with that of personalised medicine which has been evolved separately and practiced worldwide. Ayurveda can be updated and matched with the current standards of personalized medicine by following prakriti based management protocols. Being the topic currently in limelight, immunology can be the best option to explore these possibilities. Methods: The pathophysiology and management of immunological disorders and infections are viewed from the an

APA, Harvard, Vancouver, ISO, and other styles

38

Rajkumar, T. "Personalized medicine: FAQs." Indian Journal of Medical and Paediatric Oncology 31, no. 2 (2010): 72. http://dx.doi.org/10.4103/0971-5851.71661.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Jain, KK. "Personalized medicine conference." Personalized Medicine 2, no. 4 (2005): 287–90. http://dx.doi.org/10.2217/17410541.2.4.287.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Weatherall, Sir David J. "Personalized medicine – pharmacogenetics." Personalized Medicine 3, no. 1 (2006): 9. http://dx.doi.org/10.2217/17410541.3.1.9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Armitage, James O., William C. Wood, and Dan L. Longo. "Real Personalized Medicine." Journal of the National Comprehensive Cancer Network 14, no. 2 (2016): 233–36. http://dx.doi.org/10.6004/jnccn.2016.0024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Tarring, Adam. "Personalized Medicine: Foreword." Personalized Medicine 15, no. 1 (2018): 1–3. http://dx.doi.org/10.2217/pme-2017-0089.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Møldrup, Claus. "Beyond personalized medicine." Personalized Medicine 6, no. 3 (2009): 231–33. http://dx.doi.org/10.2217/pme.09.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Knoppers, Bartha Maria, and Denise Avard. "‘Principled’ personalized medicine?" Personalized Medicine 6, no. 6 (2009): 663–67. http://dx.doi.org/10.2217/pme.09.21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Daali, Youssef. "Personalized Medicine: Pharmacokinetics." Journal of Personalized Medicine 12, no. 10 (2022): 1660. http://dx.doi.org/10.3390/jpm12101660.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Biagioli, Mario, and Alain Pottage. "Patenting Personalized Medicine." Osiris 36 (June 1, 2021): 221–40. http://dx.doi.org/10.1086/713991.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Fanos, Vassilios, and Murat Yurdakök. "Personalized Neonatal Medicine." Journal of Maternal-Fetal & Neonatal Medicine 23, sup3 (2010): 4–6. http://dx.doi.org/10.3109/14767058.2010.513103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Haselden, John N., and Andrew W. Nicholls. "Personalized medicine progresses." Nature Medicine 12, no. 5 (2006): 510–11. http://dx.doi.org/10.1038/nm0506-510.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Horwitz, R. I., M. R. Cullen, J. Abell, and J. B. Christian. "(De)Personalized Medicine." Science 339, no. 6124 (2013): 1155–56. http://dx.doi.org/10.1126/science.1234106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Bruehl, Stephen. "Personalized Pain Medicine." Anesthesiology 122, no. 5 (2015): 967–68. http://dx.doi.org/10.1097/aln.0000000000000638.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!